C Bassleer
- Equine top 2%
- Rheumatology top 2%
- Osteoarthritis Treatment and Mechanisms 18
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 9
- Cell Biology top 10%
- Proteoglycans and glycosaminoglycans research 9
-
- Cell Adhesion Molecules Research 3
-
- Biological Activity of Diterpenoids and Biflavonoids 2
- Natural product bioactivities and synthesis 2
-
- Chemokine receptors and signaling 2
-
- Total Knee Arthroplasty Outcomes 1
- Co-authors
- P FranchimontLucio C. RovatiYves HenrotinR BassleerMichel MalaiseP GysenMonique TitsNancy Garbacki
- Cited by
- EquineRheumatologyPharmacology
- Journals
- Osteoarthritis and Cartilage (3 papers)Clinical Rheumatology (2 papers)Scandinavian Journal of Rheumatology (2 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
C Bassleer
22 papers receiving 584 citations
Peers
Comparison fields: 5 of 76
- Equine 54
- Rheumatology 437
- Pharmacology 210
- Cell Biology 181
- Immunology and Allergy 40
Countries citing papers authored by C Bassleer
This map shows the geographic impact of C Bassleer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Bassleer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Bassleer more than expected).
Fields of papers citing papers by C Bassleer
This network shows the impact of papers produced by C Bassleer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Bassleer. The network helps show where C Bassleer may publish in the future.
Co-authorship network
The 18 scholars most cited alongside C Bassleer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 51 | |
| 2 | 1998 | 83 | |
| 3 | 1998 | 188 | |
| 4 | 1997 | 16 | |
| 5 | 1996 | 13 | |
| 6 | Ipriflavone inhibits interleukin-I stimulated neutral metalloprotease synthesis in human chondrocytes cultivated in clusters | 1994 | 1 |
| 7 | Effects of glucosamine on differentiated human chondrocytes cultivated in clusters | 1993 | 2 |
| 8 | 1993 | 8 | |
| 9 | 1992 | 7 | |
| 10 | In-vitro evaluation of drugs proposed as chondroprotective agents. | 1992 | 70 |
| 11 | Effects of hormones and local growth factors on articular chondrocyte metabolism. | 1991 | 31 |
| 12 | 1990 | 4 | |
| 13 | 1990 | 7 | |
| 14 | Effets de l'Etodolac sur le métabolisme des chondrocytes humains cultivés en agrégats | 1989 | 2 |
| 15 | 1989 | 4 | |
| 16 | 1989 | 35 | |
| 17 | 1989 | 9 | |
| 18 | 1988 | 14 | |
| 19 | 1987 | 7 | |
| 20 | 1986 | 49 |
About C Bassleer
C Bassleer is a scholar working on Rheumatology, Equine, Pharmacology, Cell Biology and Immunology and Allergy, having authored 22 papers that have together received 619 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (18 papers), Inflammatory mediators and NSAID effects (9 papers), Proteoglycans and glycosaminoglycans research (9 papers), Cell Adhesion Molecules Research (3 papers), Biological Activity of Diterpenoids and Biflavonoids (2 papers), Chemokine receptors and signaling (2 papers), Natural product bioactivities and synthesis (2 papers) and Total Knee Arthroplasty Outcomes (1 paper). The work is most often cited by research in Equine (54 citations), Rheumatology (437 citations), Pharmacology (210 citations), Cell Biology (181 citations) and Immunology and Allergy (40 citations). C Bassleer has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include P Franchimont, Lucio C. Rovati, Yves Henrotin, R Bassleer, Michel Malaise, P Gysen, Monique Tits, Nancy Garbacki, Jean Michel Foidart and J. Damas. Their work appears in journals such as Osteoarthritis and Cartilage, Clinical Rheumatology, Scandinavian Journal of Rheumatology, Pharmacology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.